-
Dr.Kats posted an update
Another new niacin trial
Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin’s effects on lipoprotein(a) and biochemical markers in hemodialysis patients
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1625417/full
frontiersin.org
BackgroundEnd-stage kidney disease (ESRD) patients on dialysis face pronounced cardiovascular and metabolic risks due to disruptions in lipoprotein(a), phosp...